Enhanced Protective Efficacy of a Chimeric Form of the Schistosomiasis Vaccine Antigen Sm-TSP-2

The large extracellular loop of the Schistosoma mansoni tetraspanin, Sm-TSP-2, when fused to a thioredoxin partner and formulated with Freund's adjuvants, has been shown to be an efficacious vaccine against murine schistosomiasis. Moreover, Sm-TSP-2 is uniquely recognised by IgG1 and IgG3 from putatively resistant individuals resident in S. mansoni endemic areas in Brazil. In the present study, we expressed Sm-TSP-2 at high yield and in soluble form in E. coli without the need for a solubility enhancing fusion partner. We also expressed in E. coli a chimera called Sm-TSP-2/5B, which consisted of Sm-TSP-2 fused to the immunogenic 5B region of the hookworm aspartic protease and vaccine antigen, Na-APR-1. Sm-TSP-2 formulated with alum/CpG showed significant reductions in adult worm and liver egg burdens in two separate murine schistosomiasis challenge studies. Sm-TSP-2/5B afforded significantly greater protection than Sm-TSP-2 alone when both antigens were formulated with alum/CpG. The enhanced protection obtained with the chimeric fusion protein was associated with increased production of anti-Sm-TSP-2 antibodies and IL-4, IL-10 and IFN-γ from spleen cells of vaccinated animals. Sera from 666 individuals from Brazil who were infected with S. mansoni were screened for potentially deleterious IgE responses to Sm-TSP-2. Anti-Sm-TSP-2 IgE to this protein was not detected (also shown previously for Na-APR-1), suggesting that the chimeric antigen Sm-TSP-2/5B could be used to safely and effectively vaccinate people in areas where schistosomes and hookworms are endemic.

• Publication year

  2012

• Venue

  PLoS Neglected Tropical Diseases

• Publication date

  2012-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1371/journal.pntd.0001564PMID 22428079PMCID 3302818
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Schistosomiasis Vaccine: Research to Development

  2014cited by this paper
• Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths.

  2012influential reference
• Abundance of tegument surface proteins in the human blood fluke Schistosoma mansoni determined by QconCAT proteomics.

  2011cited by this paper
• A handful of 'antipoverty' vaccines exist for neglected diseases, but the world's poorest billion people need more.

  2011cited by this paper
• Polymorphism associated with the Schistosoma mansoni tetraspanin-2 gene.

  2011influential reference
• Developing vaccines to combat hookworm infection and intestinal schistosomiasis

  2010influential reference
• Neutralizing antibodies to the hookworm hemoglobinase Na-APR-1: implications for a multivalent vaccine against hookworm infection and schistosomiasis.

  2010influential reference
• Suppression of mRNAs Encoding Tegument Tetraspanins from Schistosoma mansoni Results in Impaired Tegument Turnover

  2010influential reference
• Schistosomiasis elimination: lessons from the past guide the future.

  2010cited by this paper
• Schistosoma japonicum: efficient and rapid purification of the tetraspanin extracellular loop 2, a potential protective antigen against schistosomiasis in mammalian.

  2010cited by this paper
• An enzymatically inactivated hemoglobinase from Necator americanus induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection

  2009cited by this paper
• A Comparative Study of the Spatial Distribution of Schistosomiasis in Mali in 1984–1989 and 2004–2006

  2009cited by this paper
• Peptides containing T cell epitopes, derived from Sm14, but not from paramyosin, induce a Th1 type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice.

  2008cited by this paper
• Trick or Treat: The Role of Vaccines in Integrated Schistosomiasis Control

  2008cited by this paper
• Schistosoma mansoni Tegument Protein Sm29 Is Able to Induce a Th1-Type of Immune Response and Protection against Parasite Infection

  2008cited by this paper
• The unacknowledged impact of chronic schistosomiasis

  2008cited by this paper
• DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo.

  2008cited by this paper
• Multivalent anthelminthic vaccine to prevent hookworm and schistosomiasis

  2008cited by this paper
• Current Status of Vaccines for Schistosomiasis

  2008cited by this paper
• Schistosome membrane proteins as vaccines.

  2007cited by this paper
• Transmission control for schistosomiasis - why it matters now.

  2006cited by this paper
• Proteins Exposed at the Adult Schistosome Surface Revealed by Biotinylation*S

  2006cited by this paper
• Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis

  2006influential reference
• Factors Affecting Human IgE and IgG Responses to Allergen-Like Schistosoma mansoni Antigens: Molecular Structure and Patterns of in vivo Exposure

  2006cited by this paper
• Protein production by auto-induction in high density shaking cultures.

  2005cited by this paper
• Immunity induced by the radiation‐attenuated schistosome vaccine

  2005cited by this paper
• Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach?

  2005cited by this paper
• Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa.

  2003cited by this paper
• Proteolysis of human hemoglobin by schistosome cathepsin D.

  2001cited by this paper
• Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice.

  2001cited by this paper
• Schistosomiasis vaccine:research to development.

  1998cited by this paper
• Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni.

  1994cited by this paper
• Schistosoma mansoni. Anti-egg monoclonal antibodies protect against cercarial challenge in vivo

  1984cited by this paper

• Schistosoma japonicum cathepsin L1: A potential target for anti-schistosomiasis strategies

  2025cites this paper
• A Krüppel-like factor establishes cellular heterogeneity during schistosome tegumental maintenance

  2025cites this paper
• mRNA vaccines encoding variant forms of Sm-TSP-2 confer protective immunity against Schistosoma mansoni

  2025cites this paper
• mRNA vaccines encoding variant forms of Sm-TSP-2 confer protective immunity against Schistosoma mansoni

  2025cites this paper
• Pre-clinical studies of Schistosoma mansoni vaccines: A scoping review

  2025cites this paper
• Therapeutic and vaccinomic potential of moonlighting proteins for the discovery and design of drugs and vaccines against schistosomiasis.

  2024cites this paper
• Schistosoma mansoni vaccine candidates identified by unbiased phage display screening in self-cured rhesus macaques

  2024cites this paper
• Molecular characterization and B-cell epitope analysis of the TSP11 gene in Echinococcus infection strains from Yunnan Province

  2024cites this paper
• The efficacy of cercarial antigen loaded on nanoparticles as a potential vaccine candidate in Schistosoma mansoni-infected mice

  2024cites this paper
• A Krüppel-like factor establishes cellular heterogeneity during schistosome tegumental maintenance

  2024cites this paper
• Advances in new target molecules against schistosomiasis: A comprehensive discussion of physiological structure and nutrient intake

  2023cites this paper
• Schistosoma japonicum EKLF/KLF1 is a potential immune target to tackle schistosomiasis

  2023cites this paper
• Vaccines for Human Schistosomiasis: Recent Progress, New Developments and Future Prospects

  2022cites this paper
• Recent advances in identification of potential drug targets and development of novel drugs in parasitic diseases. Part II. Parasite targets

  2022cites this paper
• Immunological evaluation of the prophylactic impact of soluble egg antigen (SEA) combined with schistosomula lung antigen preparation (SLAP) on a murine model of schistosomiasis mansoni

  2022cites this paper
• Characterisation of tetraspanins from Schistosoma haematobium and evaluation of their potential as novel diagnostic markers

  2022cites this paper
• Hookworm infection: Toward development of safe and effective peptide vaccines.

  2021cites this paper
• Immunological Considerations for Schistosoma Vaccine Development: Transitioning to Endemic Settings

  2021cites this paper
• Recent Advances and Methodological Considerations on Vaccine Candidates for Human Schistosomiasis

  2021cites this paper
• Robust Immune Response Induced by Schistosoma mansoni TSP-2 Antigen Coupled to Bacterial Outer Membrane Vesicles

  2021cites this paper
• Evaluation of Immunogenicity and Efficacy of Fasciola hepatica Tetraspanin 2 (TSP2) Fused to E. coli Heat-Labile Enterotoxin B Subunit LTB Adjuvant Following Intranasal Vaccination of Cattle

  2021cites this paper
• Immunomics-guided discovery of serum and urine antibodies for diagnosing urogenital schistosomiasis: a biomarker identification study

  2021cites this paper
• Schistosoma haematobium Extracellular Vesicle Proteins Confer Protection in a Heterologous Model of Schistosomiasis

  2020cites this paper
• Adjuvanted Schistosoma mansoni-Cathepsin B With Sulfated Lactosyl Archaeol Archaeosomes or AddaVax™ Provides Protection in a Pre-Clinical Schistosomiasis Model

  2020cites this paper
• Current status and future prospects of protein vaccine candidates against Schistosoma mansoni infection

  2020cites this paper
• Uptake of Schistosoma mansoni extracellular vesicles by human endothelial and monocytic cell lines and impact on vascular endothelial cell gene expression.

  2020cites this paper
• Partial protection with a chimeric tetraspanin-leucine aminopeptidase subunit vaccine against Opisthorchis viverrini infection in hamsters.

  2020cites this paper
• Vaccination against the digestive enzyme Cathepsin B using a YS1646 Salmonella enterica Typhimurium vector provides almost complete protection against Schistosoma mansoni challenge in a mouse model

  2019cites this paper
• Systematic screening of 96 Schistosoma mansoni cell-surface and secreted antigens does not identify any strongly protective vaccine candidates in a mouse model of infection

  2019cites this paper
• Recombinant Opisthorchis viverrini tetraspanin expressed in Pichia pastoris as a potential vaccine candidate for opisthorchiasis

  2019cites this paper
• An Efficient Schistosoma japonicum Bivalent Membrane Protein Antigen DNA Vaccine Against Schistosomiasis in Mice

  2019cites this paper
• Dissecting the schistosome cloak

  2018cites this paper
• Metazoan Parasite Vaccines: Present Status and Future Prospects

  2018cites this paper
• Flatworm-specific transcriptional regulators promote the specification of tegumental progenitors in Schistosoma mansoni

  2018cites this paper
• Kunitz-type protease inhibitor as a vaccine candidate against schistosomiasis mansoni.

  2018cites this paper
• Rational selection of immunodominant and preserved epitope Sm043300e from Schistosoma mansoni and design of a chimeric molecule for biotechnological purposes

  2018cites this paper
• In-depth proteomic characterization of Schistosoma haematobium: Towards the development of new tools for elimination

  2018cites this paper
• Surface display on Bacillus subtilis spores and vaccine potential of a Tetraspanin fromm caniogenic liver fluke Opisthorchis viverrini

  2018cites this paper
• Dynamic transcriptomes identify biogenic amines and insect-like hormonal regulation for mediating reproduction in Schistosoma japonicum

  2017cites this paper
• Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium

  2017cites this paper
• Biochemical and biophysical methodologies open the road for effective schistosomiasis therapy and vaccination.

  2017cites this paper
• Protective immune responses against Schistosoma mansoni infection by immunization with functionally active gut-derived cysteine peptidases alone and in combination with glyceraldehyde 3-phosphate dehydrogenase

  2017cites this paper
• The self‐curing phenomenon of schistosome infection in rhesus macaques: insight from in vitro studies

  2017cites this paper
• Immunomic approaches for antigen discovery of human parasites

  2016cites this paper
• Workshop report: Schistosomiasis vaccine clinical development and product characteristics.

  2016cites this paper
• A vaccine consisting of Schistosoma mansoni cathepsin B formulated in Montanide ISA 720 VG induces high level protection against murine schistosomiasis

  2016cites this paper
• Schistosomiasis vaccines: where do we stand?

  2016cites this paper
• Stem cell progeny contribute to the schistosome host-parasite interface

  2016cites this paper
• Development of a schistosomiasis vaccine

  2016influential citation
• DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection

  2015cites this paper
• Characterization of Trichomonas vaginalis rhomboid proteases and surface proteins that contribute to host: parasite interactions

  2015cites this paper
• Hookworm Na-ASP-2 - putative functions, allergenicity and implications for vaccine development

  2015cites this paper
• Eliminating Schistosomes through Vaccination: What are the Best Immune Weapons?

  2015cites this paper
• Impact of human schistosomiasis in sub-Saharan Africa

  2015cites this paper
• Proteomic Analysis on Cercariae and Schistosomula in Reference to Potential Proteases Involved in Host Invasion of Schistosoma japonicum Larvae.

  2015cites this paper
• Of Monkeys and Men: Immunomic Profiling of Sera from Humans and Non-Human Primates Resistant to Schistosomiasis Reveals Novel Potential Vaccine Candidates

  2015influential citation
• Lipid core peptide targeting the cathepsin D hemoglobinase of Schistosoma mansoni as a component of a schistosomiasis vaccine

  2014cites this paper
• An integrated immunoproteomics and bioinformatics approach for the analysis of Schistosoma japonicum tegument proteins.

  2014cites this paper
• Liver fluke vaccines in ruminants: strategies, progress and future opportunities.

  2014cites this paper
• Immunological characterization of a chimeric form of Schistosoma mansoni aquaporin in the murine model

  2014cites this paper
• Immunology of human schistosomiasis

  2014cites this paper
• Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons.

  2014cites this paper
• A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP‐2 and Sm29 was able to induce protection against infection in mice

  2014cites this paper
• Schistosomiasis.

  2014cites this paper
• An Immunomics Approach to Schistosome Antigen Discovery: Antibody Signatures of Naturally Resistant and Chronically Infected Individuals from Endemic Areas

  2014cites this paper
• Co-expression and characterization of enterocin CRL35 and its mutant in Escherichia coli Rosetta

  2014cites this paper
• Multivalent fusion protein vaccine for lymphatic filariasis.

  2013cites this paper
• Large Extracellular Loop of Tetraspanin as a Potential Vaccine Candidate for Filariasis

  2013cites this paper
• Investigating the role of tetraspanins in multinucleated giant cell formation using recombinant proteins

  2013cites this paper
• Hepatic and Intestinal Schistosomiasis: Review

  2013cites this paper
• Urinary schistosomiasis

  2013cites this paper
• Tetraspanin-2 localisation in high pressure frozen and freeze-substituted Schistosoma mansoni adult males reveals its distribution in membranes of tegumentary vesicles.

  2013cites this paper
• Solving the Riddle of the Lung-Stage Schistosomula Paved the Way to a Novel Remedy and an Efficacious Vaccine for Schistosomiasis

  2013influential citation
• Schistosomiasis vaccines: new approaches to antigen discovery and promising new candidates

  2012cites this paper
• Reversible association of tetraspanin with Trichomonas vaginalis flagella upon adherence to host cells

  2012cites this paper
• Changes in T-Cell and Monocyte Phenotypes In Vitro by Schistosoma mansoni Antigens in Cutaneous Leishmaniasis Patients

  2012cites this paper
• Novel Therapeutic and Prevention Approaches for Schistosomiasis: Review

  2012cites this paper